ENDP

Endo International plc Press Releases

$67.03
*  
0.06
0.09%
Get ENDP Alerts
*Delayed - data as of Jul. 29, 2014 12:50 ET  -  Find a broker to begin trading ENDP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ENDP Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Endo completes acquisition of Grupo Farmaceutico Somar®
7/24/2014 4:15:00 PM - PR Newswire

Endo to Announce Second Quarter 2014 Financial Results on July 31, 2014
7/15/2014 9:00:00 AM - PR Newswire

Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics
7/7/2014 7:30:00 AM - PR Newswire

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain
7/7/2014 7:00:00 AM - PR Newswire

Endo International plc Announces Pricing of Private Offering Of Senior Notes
6/25/2014 10:08:00 PM - PR Newswire

Endo International plc Announces Proposed Private Offering Of Senior Notes
6/25/2014 7:30:00 AM - PR Newswire

Endo to Acquire DAVA Pharmaceuticals
6/24/2014 9:10:00 AM - PR Newswire

Data Presented At ICE/ENDO 2014 Shows MicroBiome Therapeutics' NM504 Improves Blood Glucose Control In Diabetes And Prediabetes
6/23/2014 1:30:00 PM - PR Newswire

Islet Sciences, Inc. Highlights Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)
6/23/2014 8:00:00 AM - PR Newswire

Gelesis Presents Results of Proof of Concept Weight Loss Study
6/23/2014 7:00:00 AM - PR Newswire

Trendlines Acquires Intellectual Property from Collaboration with Endo
6/18/2014 8:00:00 AM - PR Newswire

American Medical Systems Enrolls First Patient in Embrace, a 522 Post Market Surveillance Study for the Elevate™ Anterior and Apical Prolapse System
6/9/2014 4:30:00 PM - PR Newswire

Endo Completes Sale of Early Stage Drug Discovery Portfolio
6/2/2014 7:30:00 AM - PR Newswire

Endo Completes Acquisition of Rights to Sumavel® DosePro®
5/19/2014 7:34:00 AM - PR Newswire

Zogenix Closes Sale of SUMAVEL(R) DosePro(R) Migraine Therapy to Endo International
5/19/2014 7:30:00 AM - GlobeNewswire

Endo Announces Appearances at Upcoming Conferences
5/9/2014 9:00:00 AM - PR Newswire

Endo Health Solutions Inc. Final Results and Settlement of Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022
5/6/2014 5:00:00 PM - PR Newswire

Technical Data on Top Gainers -- Research on Yelp, Endo Intl., Weight Watchers Intl., and Burlington Stores
5/2/2014 8:00:00 AM - PR Newswire

Endo Reports First Quarter Financial Results
5/1/2014 6:00:00 AM - PR Newswire